Title: Integrin #5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis
and immunotherapy efficacy in gastric cancer
Version: 0 Date: 17 Jul 2024
Reviewer:  Anwar Abouelnasr
Reviewer's report:
Dear Authors, please address the following points below:
-Have you had the opportunity to conduct scratch assays ?
- Additionally, have you performed exosome isolation and characterization to study the
characteristics of exosomes?
-In your baseline characteristics, have you included information on HER2, ITG#v, metastasis,
Who, and Lauren classifications?
-Furthermore, have you had the chance to perform a liquid biopsy to analyze circulating tumor
cells or cell-free DNA in the blood?
Title: Integrin #5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis
and immunotherapy efficacy in gastric cancer
Version: 0 Date: 17 Jul 2024
Reviewer:  Anwar Abouelnasr
Reviewer's report:
Dear Authors, please address the following points below:
-Have you had the opportunity to conduct scratch assays ?
- Additionally, have you performed exosome isolation and characterization to study the
characteristics of exosomes?
-In your baseline characteristics, have you included information on HER2, ITG#v, metastasis,
Who, and Lauren classifications?
-Furthermore, have you had the chance to perform a liquid biopsy to analyze circulating tumor
cells or cell-free DNA in the blood?
Please review this paper.
user
Title: Integrin #5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis
and immunotherapy efficacy in gastric cancer
Version: 0 Date: 17 Jul 2024
Reviewer:  Anwar Abouelnasr
Reviewer's report:
Dear Authors, please address the following points below:
-Have you had the opportunity to conduct scratch assays ?
- Additionally, have you performed exosome isolation and characterization to study the
characteristics of exosomes?
-In your baseline characteristics, have you included information on HER2, ITG#v, metastasis,
Who, and Lauren classifications?
-Furthermore, have you had the chance to perform a liquid biopsy to analyze circulating tumor
cells or cell-free DNA in the blood?
assistant